Concorde Asset Management’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-52,000
Closed -$30K 171
2022
Q1
$30K Sell
52,000
-2,500
-5% -$1.79K 0.02% 152
2021
Q4
$56K Hold
54,500
0.03% 167
2021
Q3
$76K Sell
54,500
-6,400
-11% -$11.6K 0.04% 192
2021
Q2
$136K Buy
60,900
+1,440
+2% +$3.36K 0.08% 191
2021
Q1
$170K Buy
59,460
+960
+2% +$2.94K 0.1% 208
2020
Q4
$154K Buy
58,500
+28,800
+97% +$78.2K 0.09% 148
2020
Q3
$51K Buy
+29,700
New +$57.8K 0.03% 178

Other funds holding NBEV

Concorde Asset Management's NBEV Position: Q2 2022 in Review

Concorde Asset Management sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q2 2022, closing a stake of 52,000 shares — an estimated $30K sold.

Concorde Asset Management first reported a position in NBEV in Q3 2020 and held it in 7 quarters. The position peaked at $170K in Q1 2021. 81 funds tracked by Wall St. Rank hold NBEV as of Q2 2022.

  • Concorde Asset Management reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q2 2022 after selling out during the quarter.
  • Concorde Asset Management sold 52,000 NewAge, Inc. Common Stock (Delaware) shares in Q2 2022, an estimated $30K.
  • Concorde Asset Management first reported a position in NewAge, Inc. Common Stock (Delaware) in Q3 2020 and held it in 7 quarters.
  • Concorde Asset Management's NewAge, Inc. Common Stock (Delaware) position peaked at $170K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q2 2022.

Based on Concorde Asset Management's 13F filing for Q2 2022, filed 5 Aug 2022.